Demand Surge amid COVID-19 Pandemic

Although patients showed reluctance to the use of inhaling medication devices like nebulisers during the initial months of COVID-19 pandemic, increasing recommendation from physicians remained the key factor bolstering demand for these life-saving devices. With an increasing number of cases such as those with shortness of breath/difficulty breathing, nebuliser sales are likely to see an upswing for a while.

Get Exclusive PDF Sample Copy Of This Report @ https://www.fairfieldmarketresearch.com/report/nebuliser-market

Jet Nebuliser Sales Dominant

While jet nebulisers continue to be the bestseller on the back of an economic price point, mesh nebulisers have been recently witnessing rising adoption owing to a greater level of convenience. The latter is particularly expected to gain traction in clinical trials during drug development, attributing to their portable feature, and easy operability. Increasing awareness about the capability of mesh nebulisers to prevent potential drug wastage will further boost demand. Of late, ultrasonic nebulisers are rapidly emerging attractive, indicates the report. Continuous innovations around the lightweight, portable, compact, and smart features of nebulisers will also

Asian Markets Reap Benefits of Pricing Regulation

Nebuliser sales in North America continue to be dominant on account of robust prevalence of respiratory conditions, and alarmingly high proportion of tobacco consumers. The market in Europe is also expected to retain a significant spot on the back of an exponentially rising demand for nebulisers to be used at nursing care units, delivery rooms, and postoperative rooms. The region also continues to benefit from otherwise soaring demand for respiratory devices. Asian markets on the other hand are expected to gain from greater emphasis on preventive healthcare, and the ever-expanding geriatric patient population. The role of governments is extremely pivotal here, suggests the report. Growing affordability through price regulation amid COVID-19 pandemic is another strong factor contributing heavily to market growth in the region.

Competition Landscape Analysis

Fairfield Market Research in its report provides an insightful analysis of the competition landscape, covering detailed financial, and strategic profiling of some of the major players that drive this competitive landscape. Koninklijke Philips N.V., PARI Respiratory Equipment, Inc., and Omron Healthcare Co. collectively account for a considerably significant revenue share in nebuliser market. Besides, other prominent players include Becton, Dickinson and Company, Agilent Technologies, GF Health Products Inc., Glaxosmithkline, Merck, GE Healthcare Ltd., Bayer, Johnson & Johnson, Roche, Pfizer, 3M, Novartis, Cook Medical, and Sanofi.

For more information about this report @ https://www.fairfieldmarketresearch.com/report/nebuliser-market